EGF and IL-1α modulate the release of collagenase, gelatinase and TIMP-1 as well as the release of calcium by rabbit calvarial bone explants

Journal of Periodontal Research

Volumn 33, Issue 1, 1998, Pages 65-72

  Van Der Zee, Erwin ^a   Jansen, Ineke ^a   Hoeben, Kees ^b   Beertsen, Wouter ^a   Everts, Vincent ^a,b,c  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Bone resorption; Calcium; Collagen; Collagenase; Cytokines; EGF; Gelatinase; IL 1 ; TIMP; Tissue culture

Indexed keywords

CALCIUM; COLLAGENASE; DIAGNOSTIC AGENT; EPIDERMAL GROWTH FACTOR; GELATINASE; GELATINASE A; GELATINASE B; INTERLEUKIN 1; METALLOPROTEINASE; PROTEINASE INHIBITOR; RADIOPHARMACEUTICAL AGENT; THYMIDINE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRITIUM;

ANALYSIS OF VARIANCE; ANIMAL; ARTICLE; CULTURE TECHNIQUE; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYMOLOGY; METABOLISM; OSTEOLYSIS; PERIOSTEUM; RABBIT; SKULL;

ANALYSIS OF VARIANCE; ANIMALS; BONE RESORPTION; CALCIUM; COLLAGENASES; CULTURE TECHNIQUES; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPIDERMAL GROWTH FACTOR; GELATINASES; INTERLEUKIN-1; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; METALLOENDOPEPTIDASES; PERIOSTEUM; PROTEASE INHIBITORS; RABBITS; RADIOPHARMACEUTICALS; SKULL; THYMIDINE; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TRITIUM;

EID: 0031607523     PISSN: 00223484     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0765.1998.tb02293.x     Document Type: Article

References (48)

1. Everts V, Delaissé JM,. Korper W, Beertsen W. Involvement of matrix metalloproteinases and cysteine proteinases in degradation of bone matrix. In: Davidovitch Z, ed. The biological mechanisms of tooth eruption, resorption, and replacement by oral implants. Alabama: EBSCO Media, 1994: 85-97.
2. Chambers TJ, Darby JA, Fuller K. Mammalian collagenase predisposes bone surfaces to osteoclastic resorption. Cell Tissue Res 1985: 241: 671-675.
3. Horton MA, Taylor ML, Arnett TR, Helfrich MH. ArgGly-Asp (RGD) peptides and the anti-vitronectin receptor antibody 23C6 inhibit dentine resorption and cell spreading by osteoclasts. Exp Cell Res 1991; 195: 368-375.
4. Baron R, Neff L, Louvard D, Courtoy PJ. Cell-mediated extracellular acidification and bone resorption: evidence for a low pH in resorbing lacunae and localization of a 100-kD lysosomal membrane protein at the osteoclast ruffled border. J Cell Biol 1985; 101: 2210-2222.
5. Vaes G. Cellular biology and biochemical mechanism of bone resorption. Clin Orthop Rel Res 1988; 231: 239-271.
6. Baron R. Molecular mechanisms of bone resorption by the osteoclast. Anat Rec 1989; 224: 317-324.
7. Delaissé JM, Vaes G. Mechanism of mineral solubilization and matrix degradation in osteoclastic bone resorption. In: Rifkin BR, Gay CV, eds. Biology and physiology of the osteoclast. Boca Raton: CRC Press, 1992: 289-314.
8. Delaissé JM, Eeckhout Y, Vaes G. In vivo and in vitro evidence for the involvement of cysteine proteinases in bone resorption. Biochem Biophys Res Commun 1984; 125: 441-447.
9. Delaissé JM, Eeckhout Y, Sear C, Galloway A, McCullagh K, Vaes G. A new synthetic inhibitor of mammalian tissue collagenase inhibits bone resorption in culture. Biochem Biophys Res Commun 1985; 133: 483-490.
10. Everts V, Dellaissé JM, Korper W. Niehof A, Vaes G, Beertsen W. Degradation of collagen in the bone-resorbing compartment underlying the osteoclast involves both cysteine proteinases and matrix metalloproteinases. J Cell Physiol 1992: 150: 221-231.
11. Sakamoto S, Sakamoto M. Biochemical and immunohistochemical studies on collagenase in resorbing bone in tissue culture. J Periodont Res 1982; 17: 523-526.
12. Sakamoto S, Sakamoto M. Bone collagenase, osteoblasts and cell-mediated bone resorption. Bone Min Res 1986; 4: 48-102.
13. Delaissé JM, Eeckhout Y, Vaes G. Bone-resorption agents affect the production and distribution of procollagenase as well as the activity of collagenase in bone tissue. Endocrinology 1988; 123: 264-276.
14. Eeckhout Y, Delaissé JM. The role of collagenase in bone resorption. Pathol Biol 1988; 36: 1139-1146.
15. Delaissé JM, Eeckhout Y, Neff L, et al (Pro)collagenase (matrix metalloproteinase-1) is present in rodent osteoclasts and in the underlying bone-resorbing compartment. J Cell Sci 1993; 106: 1071-1082.
16. Fuller K, Chambers TJ. Localisation of mRNA for collagenase in osteocytic, bone surface and chondrocytic cells but not osteoclasts. J Cell Sci 1995; 108: 2221-2230.
17. Hill PA, Murphy G, Docherty AJP, et al. The effects of selective inhibitors of matrix metalloproteinases (MMPs) on bone resorption and the identification of MMPs and TIMP-1 in isolated osteoclasts. J Cell Sci 1994; 107: 3055-3064.
18. Mundy GR. Inflammatory mediators and the destruction of bone. J Periodont Res 1991; 26: 213-217.
19. Meikle MC, McGarrity AM, Thomson BM, Reynolds JJ. Bone-derived growth factors modulate collagenase and TIMP (tissue inhibitor of metalloproteinases) activity and type I collagen degradation by mouse calvarial osteoblasts. Bone Min 1991: 12: 41-55.
20. Van der Zee E, Everts V, Hoeben K, Beertsen W. Interleukin-1α and EGF synergistically enhance the release of collagenase by periosteal connective tissue in vitro. Matrix 1993; 13: 389-398.
21. Van der Zee E, Everts V, Hoeben K, Beertsen W. Immunolocalization of collagenase in rabbit periosteal tissue explants and extraction of the enzyme. The effect of the cytokines IL-1α and EGF. J Cell Sci 1994: 107: 1047-1053.
22. Wlodarski KH. Normal and heterotopic periosteum. Clin Orthop Rel Res 1989: 241: 265-277.
23. Bird TA, Saklatvala J. Down-modulation of epidermal growth factor receptor affinity in fibroblasts treated with interleukin 1 or tumor necrosis factor is associated with phosphorylation at a site other than threonine 654. J Biol Chem 1990; 265: 235-240.
24. Everts V, Hembry RM, Reynolds JJ, Beertsen W. Metalloproteinases are not involved in the phagocytosis of collagen fibrils by fibroblasts. Matrix 1989; 9; 266-276.
25. Cawston TE, Barrett A. A rapid reproducible assay for collagenase using (1-14C) acetylated collagen. Anal Biochem 1979; 99: 340-345.
26. Dean DD, Martel-Pelletier J, Pelletier JP, Howell DS, Woessner JF. Evidence for metalloproteinase and metalloproteinase inhibitor imbalance in human osteoarthritic cartilage. J Clin Invest 1989; 84: 678-685.
27. Hembry RM, Murphy G, Reynolds JJ. Immunolocalization of tissue inhibitor of metalloproteinases (TIMP) in human cells. Characterization and use of a specific antiserum. J Cell Sci 1985; 73: 105-119.
28. Gavrilovic J, Heinbry RM, Reynolds JJ, Murphy G. Tissue inhibitor of metalloproteinases (TIMP) regulates extracellular type I collagen degradation by chondrocytes and endothelial cells. J Cell Sci 1987; 87: 357-362.
29. Green DD, Hembry RM, Atkinson SJ, Reynolds JJ, Meikle MC. Immunolocalization of collagenase and tissue inhibitor of metaloproteinases (TIMP) in mechanically deformed fibrous joints. Am J Orthod Dent Orthop 1990; 97: 281-288.
30. Murphy G, McAlpine CG, Poll CT, Reynolds JJ. Purification and characterization of a bone metalloproteinase that degrades gelatin and types IV and V collagen. Biochim Biophys Acta 1985; 831: 49-58.
31. Everts V, Hoeben K, Beertsen W. The release of tissue inhibitor of metalloproteinases by calvarial bone explants and its Immunolocalization. Bone Miner 1993; 22: 43-55.
32. Vaes G. The release of collagenase as an inactive proenzyme by bone explants in culture. Biochem J 1972; 126: 275-289.
33. Eeckhout Y, Delaissé JM, Vaes G. Direct extraction and assay of bone tissue collagenase and its relation to parathyroid-hormone-induced bone resorption. Biochem J 1986; 239: 793-796.
34. Hill PA, Reynolds JJ, Meikle MC. Inhibition of stimulated bone resorption in vitro by TIMP-1 and TIMP-2. Biochim Biophys Acta 1993; 1177: 71-74.
35. Raisz LG, Simmons HA, Sandberg AL, Canalis E. Direct stimulation of bone resorption by epidermal growth factor. Endocrinology 1980; 107. 270-273.
36. Gowen M, Wood DD, Ihrie EJ, McGuire MKB, Russell GG. An interleukin 1 like factor stimulates bone resorption in vitro. Nature 1983; 306: 378-380.
37. Lorenzo JA, Sousa SL, Centrella M. Interleukin-1 in combination with transforming growth factor-α produces enhanced bone resorption in vitro. Endocrinology 1988; 123: 2194-2200.
38. Okada Y, Naka K, Kawamura K, et al. Localisation of matrix metalloproteinase 9 in osteoclasts: implications for bone resorption. Lab Invest 1995; 72: 311-322.
39. Reponen P, Sahlberg C, Munaut C, Thesleff I, Tryggvason K. High expression of 92-kD type IV collagenase (gelatinase B) in the osteoclast lineage during mouse development. J Cell Boil 1994; 124: 1091-1102.
40. Blavier L, Delaissé JM. Matrix metalloproteinases are obligatory for the migration of preosteoclasts to the developing marrow cavity of primitive long bones. J Cell Sci 1995; 108: 3649-3659.
41. Witty JP, Foster SA, Stricklin GP, Matrisian LM, Stern PH. Parathyroid hormone-induced resorption in fetal rat limb is associated with the production of the metalloproteinases collagenase and gelatinase B. J Bone Min Res 1996; 11: 72-78.
42. Lorenzo JA, Pilbeam CC, Kalinowski JF, Hibbs MS. Production of both 92- and 72-kDa gelatinases by bone cells. Matrix 1992; 12: 282-290.
43. Howard EW, Bullen EC, Banda MJ. Preferential inhibition of 72- and 92-kDa gelatinases by tissue inhibitor of metalloproteinases-2. J Biol Chem 1991; 226: 13,070-13,075.
44. Murphy G, Cartwright EC, Sellers A, Reynolds JJ. The detection and characterisation of collagenase inhibitors from rabbit tissues in culture. Biochim Biophys Acta 1977; 483: 493-498.
45. Sellers A, Reynolds JJ. Identification and partial characterization of an inhibitor of collagenase from rabbit bone. Biochem J 1977; 167: 353-360.
46. Cawston TE, Galloway WA, Mercer E, Murphy G, Reynolds JJ. Purification of rabbit bone inhibitor of collagenase. Biochem J 1981; 195: 159-165.
47. Rifas L, Halstead LR, Peck WA, Avioli LV, Welgus HG. Human osteoblast in vitro secrete tissue inhibitor of metalloproteinases and gelatinase but not interstitial collagenase as major cellular products. J Clin Invest 1989; 84: 686-694.
48. Shimizu H, Sakamoto M, Sakamoto S. Bone resorption by isolated osteoclasts in living versus devitalized bone: differences in mode and extent and the effects of human recombinant tissue inhibitor of metalloproteinases. J Bone Min Res 1990; 5: 411-418.